Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_provenance.
- NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_assertion description "[STS growth and metastasis can be interrupted by combined low-dose doxorubicin and anti-VEGFR2, a strategy that attacks STS-associated endothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_provenance.
- NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_assertion evidence source_evidence_literature NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_provenance.
- NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_assertion SIO_000772 16951193 NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_provenance.
- NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_assertion wasDerivedFrom befree-20140225 NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_provenance.
- NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_assertion wasGeneratedBy ECO_0000203 NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP303693.RAbgmeGJvrdTXLSTpR3VRM2LeQSFHsDhwz1t-qZrP6CQs130_provenance.